CARGO Therapeutics Inc (NASDAQ:CRGX) shares traded -74.30% lower at $3.39 on Wall Street last session.
CRGX stock price is now -76.87% away from the 50-day moving average and -80.82% away from the 200-day moving average. The market capitalization of the company currently stands at $156.04M.
On January 31, 2025, Truist Downgraded its previous ‘Buy’ rating to ‘Hold’ on the stock reducing its target price from $32 to quote $7, while ‘Piper Sandler’ rates the stock as ‘Neutral’
In other news, Chapman Gina, President & CEO sold 7,166 shares of the company’s stock on Sep 18 ’24. The stock was sold for $179,775 at an average price of $25.09. Upon completion of the transaction, the President & CEO now directly owns 103,905 shares in the company, valued at $0.35 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Sep 19 ’24, President & CEO Chapman Gina sold 2,975 shares of the business’s stock. A total of $74,457 was realized by selling the stock at an average price of $25.03. This leaves the insider owning 103,905 shares of the company worth $0.35 million. A total of 30.34% of the company’s stock is owned by insiders.
During the past 12 months, CARGO Therapeutics Inc has had a low of $10.91 and a high of $33.92. As of last week, the company has a debt-to-equity ratio of 0.07, a current ratio of 18.95, and a quick ratio of 18.95. The fifty day moving average price for CRGX is $14.9273 and a two-hundred day moving average price translates $17.763624 for the stock.
The latest earnings results from CARGO Therapeutics Inc (NASDAQ: CRGX) was released for 2024-09-30.
